APDN
NASDAQ
$5.62
Applied Dna Sciences Inc (APDN)
Applied DNA Sciences, Inc. is a leading provider of DNA-based technology solutions, specializing in applications for pre-clinical drug development and manufacturing, as well as supply chain security, anti-counterfeiting, and anti-theft technologies. With a strong market presence across the United States, Europe, and Asia, the company leverages its innovative nucleic acid-based in vitro diagnostic technologies to address critical challenges in various industries. Headquartered in Stony Brook, New York, Applied DNA is positioned at the intersection of biotechnology and security, offering unique solutions that enhance product integrity and safety.
Sector:
Healthcare
Industry:
Diagnostics & Research
Strong Sell
Target: $1.50 (-73.31%)
Market Cap
$3.21M
P/B Ratio
0.44
Free Cash Flow Yield
-412.50%
Price Chart
Valuation
Market Cap$3.21M
P/S0.97
P/B0.44
Profitability
Total Revenue (TTM)$3.74M
Gross Profit (TTM)$1.25M
EBITDA-$13M
Operating Margin-1214%
EPS-$64.87
Financial Health
Debt-to-Equity4.6%
Free Cash Flow Yield-412.50%
Growth & Risk
Revenue 5Y CAGR+0.04%
Sharpe Ratio-1.67